Search research articles
Contact Us
Filters
Showing results (171-180 of 295) with videos related to
Page
of 30
Sort By:
Japanese Journal of Clinical Oncology
|
July 17, 2008
A phase i study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer
Junichi Matsubara, Yasuhiro Shimada, Atsuo Takashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2010
Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors
Tetsuya Hamaguchi, Toshihiko Doi, Takako Eguchi-Nakajima, et al.
Japanese Journal of Clinical Oncology
|
August 31, 2004
Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial
Takekazu Yamao, Yasuhiro Shimada, Kuniaki Shirao, et al.
Cancer Science
|
December 11, 2008
Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer
Yoshinori Hirashima, Yasuhide Yamada, Junichi Matsubara, et al.
Cancer Chemotherapy and Pharmacology
|
August 20, 2011
Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer
Taroh Satoh, Yasuhide Yamada, Kei Muro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 18, 2011
Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma
Natsuko Tsuda Okita, Ken Kato, Daisuke Takahari, et al.
Japanese Journal of Clinical Oncology
|
December 3, 2019
Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial)
Kenichi Miyamoto, Atsuo Takashima, Junki Mizusawa, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 7, 2015
Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients
Tetsuji Terazawa, Hitoshi Nishitani, Ken Kato, et al.
Oncology
|
November 27, 2008
Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer
Daisuke Takahari, Yasuhide Yamada, Natuko T Okita, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 10, 2009
Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine
Makiko Ono, Kuniaki Shirao, Atsuo Takashima, et al.
Page
of 30
Search research articles
Search
Showing results (171-180 of 295) with videos related to
Sort By:
Page
of 30
Japanese Journal of Clinical Oncology
|
July 17, 2008
A phase i study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer
Junichi Matsubara, Yasuhiro Shimada, Atsuo Takashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2010
Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors
Tetsuya Hamaguchi, Toshihiko Doi, Takako Eguchi-Nakajima, et al.
Japanese Journal of Clinical Oncology
|
August 31, 2004
Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial
Takekazu Yamao, Yasuhiro Shimada, Kuniaki Shirao, et al.
Cancer Science
|
December 11, 2008
Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer
Yoshinori Hirashima, Yasuhide Yamada, Junichi Matsubara, et al.
Cancer Chemotherapy and Pharmacology
|
August 20, 2011
Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer
Taroh Satoh, Yasuhide Yamada, Kei Muro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 18, 2011
Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma
Natsuko Tsuda Okita, Ken Kato, Daisuke Takahari, et al.
Japanese Journal of Clinical Oncology
|
December 3, 2019
Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial)
Kenichi Miyamoto, Atsuo Takashima, Junki Mizusawa, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 7, 2015
Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients
Tetsuji Terazawa, Hitoshi Nishitani, Ken Kato, et al.
Oncology
|
November 27, 2008
Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer
Daisuke Takahari, Yasuhide Yamada, Natuko T Okita, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 10, 2009
Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine
Makiko Ono, Kuniaki Shirao, Atsuo Takashima, et al.
Page
of 30